Omega Healthcare Investors (NYSE:OHI) Issues FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Friday morning. The company provided EPS guidance of 2.700-2.800 for the period, compared to the consensus EPS estimate of 2.730. The company issued revenue guidance of -.

Omega Healthcare Investors Price Performance

NYSE:OHI traded down $0.25 during trading hours on Monday, hitting $31.09. 882,634 shares of the company’s stock traded hands, compared to its average volume of 1,740,272. The firm has a market cap of $7.68 billion, a P/E ratio of 28.07, a P/E/G ratio of 10.26 and a beta of 0.92. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $34.77. The business’s fifty day simple moving average is $30.98 and its two-hundred day simple moving average is $30.97. The company has a quick ratio of 6.76, a current ratio of 6.68 and a debt-to-equity ratio of 1.36.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th will be issued a dividend of $0.67 per share. The ex-dividend date is Monday, April 29th. This represents a $2.68 dividend on an annualized basis and a yield of 8.62%. Omega Healthcare Investors’s dividend payout ratio is currently 241.44%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on OHI shares. JMP Securities restated a market perform rating on shares of Omega Healthcare Investors in a research report on Monday. Deutsche Bank Aktiengesellschaft began coverage on Omega Healthcare Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $36.00 price objective on the stock. Truist Financial increased their price objective on Omega Healthcare Investors from $31.00 to $32.00 and gave the stock a hold rating in a research note on Tuesday, April 2nd. Bank of America cut Omega Healthcare Investors from a buy rating to a neutral rating and dropped their target price for the company from $33.00 to $31.00 in a research report on Tuesday, January 16th. Finally, Wells Fargo & Company raised Omega Healthcare Investors from an equal weight rating to an overweight rating and increased their target price for the company from $31.00 to $35.00 in a research report on Monday, February 26th. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of Hold and an average price target of $33.63.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.